Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
A budget impact analysis from a health system perspective indicated the use of tirzepatide could result in an additional financial burden ranging from $80 million to $490 million over 5 years on the National Health Insurance System (NHIS) (Zhang and McAdam Marx 2023)
doi: 10.1111/obr.12836 6 NICE guideline
You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a genetic condition that increases the risk of endocrine tumours
Maybe in the future if it loses effectiveness, Ill consider trying Mounjaro." u/sandra_nz Others highlighted how cost shaped their decision to switch: "I stopped Wegovy because I couldnt afford the maintenance dose of 2.4mg anymore and weight loss slowed down
US$ 26.13
US$ 28.66
US$ 21.22
US$ 23.73
.png)
US$ 24.51
US$ 25.92
US$ 27.44
